Article information
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
E.A. Abdi, R. Goel, S. Bishop, G.O. Bain.
Peripheral carcinoid tumours of the lung: A clinicopathological study.
J. Surg Oncol, 39 (1988), pp. 190-196
[2.]
B.J. Addis.
Neuroendocrine diOerentiation in lung carcinoma.
Thorax, 50 (1995), pp. 113-115
[3.]
Y. Ariyoshi.
Therapeutic significance of neuronspecitic enolase (NSE) in lung cancer.
Proc Am Assoc Clin Oncol, 5 (1986), pp. 23
[4.]
M.G. Arrigoni, L.B. Woolner, P.E. Bernatz.
A typical carcinoid tumors of the lung.
J Thorac Cardiovasc Surg, 64 (1972), pp. 413-421
[5.]
A.C. Arroliga, D. Carter, R.A. Matthay.
Other primary neoplasms of the lung.
pp. 1-5
[6.]
R. Azfvedo-Bernarda.
A vanços técnicos na caracterição du cancro do pulmão.
Via Pneumológica, V (1992), pp. 139-143
[7.]
S.E. Bates.
Clinical applications of serum tumor markers.
Annals Intern Med, 115 (1991), pp. 623-638
[8.]
S.B. Baylin, A.F. Gazdar.
Endocrine biochemistry in the spectrum of human lung cancer: Implications for the cellular origin of small cell carcinoma.
pp. 123-145
[9.]
K.G. Bensch, B. Corrin, R. Pariente, H. Spencer.
Oat-cell carcinoma of the lung. its origin and relationship to bronchial carcinoid.
Cancer, 22 (1968), pp. 1163-1172
[10.]
J.R. Benfield.
Neuroendocrine neoplasms of the lung.
J Thome Cardiovasc Surg, 100 (1990), pp. 628-629
[11.]
G. Bepler, et al.
Clinical relevance of histologic subtyping in small cell lung cancer.
Cancer, 64 (1989), pp. 74-79
[12.]
H.H. Berendsen, L. Leij, S. Poppema, P.E. Postmus, A. Boes, H.J. Sluiter, H. The.
Clinical characterization of non-small -cell lung cancer showing neuroendocrine differetiation features.
J Clin Oncol, 7 (1989), pp. 1614-1620
[13.]
C. Bernstein, J. Mcgoey, M. Lertzman.
Recurrent bronchial carcinoid tumor.
Chest, 95 (1989), pp. 693-694
[14.]
J.F. Bishop.
The role of colony-stimulating factors in small cell lung cancer.
Lung cancer, 9 (1993), pp. S75-S83
[15.]
O.S. Bonikos, K.G. Bensch, R.W. Jamplis.
Peripheral pulmonary carcinoid tumors.
Cancer, 37 (1976), pp. 1977-1998
[16.]
E. Brambilla, et al.
neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes.
Am J Clin Pathol, 98 (1992), pp. 88-97
[17.]
J.L. Broers, et al.
Novel antigens characterstic of neuroendocrine malignancies.
Cancer, 67 (1991), pp. 619-633
[18.]
G. Buccheri, D. Ferrigno, A. Rosso, F. Vola.
Further evidence in favour of chemotherapy for inoperable non-small cell lung cancer.
Lung Cancer, 6 (1990), pp. 87-98
[19.]
P.A. Bunn, et al.
Chemotherapy in small cell lung cancer: A consensus report.
Lung cancer, 5 (1989), pp. 127-134
[20.]
F. Capron.
Anatomopathologie des carcinomes bronchiques. Donnés classiques et nouveaux concepts.
Rev Prat (Paris), 43 (1993), pp. 815-819
[21.]
J. Carles, et al.
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Lung Cancer, 10 (1993), pp. 209-219
[23.]
D.N. Carney, A.F. Gazdar, M. Nau, J.D. Minna.
Biological heterogeneity of small cell lung cancer.
Semin Oncol, 12 (1985), pp. 289-303
[24.]
D.N. Carney, et al.
Serum neuronspecific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Lancet, 1 (1982), pp. 538-585
[25.]
D. Carter, R. Yesner.
Carcinomas of the lung with neuroendocrine differentiation.
Semin Diagn Pathol, 2 (1985), pp. 235-254
[26.]
D. Chapleau, A. Page, A. Verdant, G. Beauchamp, G. Nakhle.
Bronchial carcinoids: Long term prognostic factors.
Can J Surg, 34 (1991), pp. 111-114
[27.]
D.G. Davila, W.F. Dunn, H.D. Tazelaar, P.C. Pairolero.
Bronchial carcinoid tumors.
Mayo Clin in Proc, 68 (1993), pp. 795-803
[28.]
A.P. Dhillon, et al.
Neural markers in carcinoma of the lung.
Br J Cancer, 51 (1985), pp. 645-652
[29.]
R.A. Erlandson.
Carcinoid and a typical carcinoid (well- differentiated neuroendocrine carcinoma) of the lung.
Ultrastruct Pathol, 13 (1989), pp. 333-339
[30.]
B.B. Forster, N.L. Müller, R.R. Miller, B. Nelems, K.G. Evans.
Neuroendocrine carcinomas of the lung: chnical. radiological, and pathologic correlation.
Radiology, 170 (1989), pp. 441-445
[31.]
A.E. Fraire, E.H. Johnson, R. Yesner, X.B. Zhang, H.J. Spjut, S.O. Greenberg.
Prognostic significance of htslopathologic subtype and stage in small cell lung cancer.
Human Pathol, 23 (1992), pp. 520-528
[32.]
pp. 1476-1497
[33.]
A.F. Gazdar.
Pathology’s impact on lung cancer management.
Contemporany Oncol, Summer (1994), pp. 30-35
[34.]
A.F. Gazdar, D.N. Carney.
pp. 4
[35.]
A.F. Gazdar, R.J. Linnoila.
The pathology of lung cancer.
Changing concepts and newer diagnostic techniques Semin Oncol, 15 (1988), pp. 215-225
[36.]
A.F. Gazdar, E.M. McDowell.
Pathobiology of lung cancers.
pp. 1-42
[37.]
G. Giaccone.
Second line chemotherapy in small cell lung cancer.
Lung Cancer, 5 (1989), pp. 207-213
[38.]
R.J. Ginsberg.
Surgery and small cell lung cancer-an over view.
Lung Cancer, 5 (1989), pp. 232-236
[39.]
R.J. Ginsberg, F.A. Shepherd.
Surgerey for small cell lung cancer.
Semin Radiot Oncol, 5 (1995), pp. 40-43
[40.]
C.D. Givens Jr., J.J. Marini.
Transbronchial needle aspiration of a bronchial tumor.
Chest, 88 (1985), pp. 152-153
[41.]
G. Gomez, G. Estrada, C. Leon, C. Rodriguez, F. Alameda.
Tumor carcinoide bronquial.
Arch Bronconeumol, 21 (1985), pp. 217-224
[42.]
J.R. Gosney, M.A. Gosney, M. Lye, S.A. Buti.
Reliablity of cornmerctally available Immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsis of bronchial carcinoma.
Thorax, 50 (1994), pp. 116-120
[43.]
V.E. Gould, R.J. Linnoila, V.A. Memoli, W.H. Warren.
Neuroendocrine cells and neuroendocrine neoplasms or the lung.
Pathol Annu, 18 (1983), pp. 287-330
[44.]
V.E. Gould, W.H. Warren.
Neuroendocrine neoplasms of the bronchopulmonary tract.
Lung Cancer, 11 (1994), pp. 199-200
[45.]
S.L. Graziano.
The use of neuroendocrine immunoperoxtdase markers to predict chemotherapy response in pauents with non-small-cell lung cancer.
J Clin Oncol, 7 (1989), pp. 1398-1406
[46.]
T.H. Grote, W.R. Macon, B. Davis, F.A. Greco, D.H. Johnson.
Atypical Carcinoid of the lung. A distinct clinicopathologic entity.
Chest, 93 (1988), pp. 370-375
[47.]
J.D. Hainesworth, Educational Book.
Clinical approach to neuroendocrine neoplasia.
ASCO, (1994), pp. 249-251
[48.]
S.P. Hammar.
Common neoplasms.
pp. 85-136
[49.]
S. Hammar, D. Bockus, F. Remington, L. Cooper.
Unusual spectrum of neuroendocrine lung neoplasms.
UltraStruct Pathol, 13 (1989), pp. 15-360
[50.]
M.E. Hammond, W.T. Sause.
Large cell neuroendocrine tumors of the lung. Clinical significance and histopathologic definition.
Cancer, 56 (1985), pp. 1624-1629
[51.]
D.H. Harpole Jr., J.M. Feldman, S. Buchanan, W.G. Young, W.G. Wolfe.
Bronchial carcinoid tumors: A retrospective analysts of 126 patients.
Ann Thorac Surg, 54 (1992), pp. 50-55
[52.]
M. Havens, R. Kosinski, P. Cohen, J.M. Orenstein.
Atypical endocrine tumors of the lung: A histologic. ultras-tructural. and clinical study or 19 cases.
Human Pathol, 17 (1986), pp. 1264-1277
[53.]
F.R. Hirsch.
The clinical implication of neuroendocrine markers in non-small cell lung cancer.
Lung Cancer, 11 (1994), pp. 201-202
[54.]
F.R. Hirsch, M.J. Mathews, S. Aisner, et al.
Histopathologic classification of small cell lung cancer. Changig concepts and terminology.
Cancer, 62 (1988), pp. 973-977
[55.]
F.R. Hirsch, K. Sterlind, H.H. Hansen.
The prognostic significance of histopathologic subtypmg of small cell carcinoma of the lung according to the classification of the World Health Organization. A study of 375 consecutive patients.
Cancer, 52 (1983), pp. 2144-2150
[56.]
F.R. Hirsch, K. Rygaard.
The role of the pathologist in the management of lung cancer in the 90s.
Lung Cancer, 9 (1993), pp. 111-118
[57.]
F.R. Hirsch, B.G. Skov.
Neuroendocrine characteristtcs in bronchogenic adenocarcmoma and its chemical relevance.
Lung Cancer, 9 (1993), pp. 89-96
[58.]
R. Hurt, M. Bates.
Carcinoid tumors of the bronchus: a 33 year experience.
Thorax, 39 (1984), pp. 617-623
[59.]
M.C. Iannuzi, C.H. Scoggin.
Small cell lung cancer.
Am Rev Respir Dis, 134 (1986), pp. 593-608
[60.]
D.C. Ihde.
Prophylatic cranial irradiation: Current controversies.
Lung cancer, 9 (1993), pp. S69-S74
[61.]
T. Ishida, et al.
Surgical treatment of patients wtth small cell carcinoma of the lung: A histochemical and Immunohistochemical study.
J Surg Oncol, 40 (1989), pp. 188-193
[62.]
T. Ishida, et al.
Carcinoid tumor of the lung. Clinicopathological and immunochemical studies.
Eur Surg Oncol, 18 (1992), pp. 180-187
[63.]
G. Jackson-York, B.H. Davis, W.H. Warren, V.E. Gould, V.A. Memoli.
Flow cytometric DNA content analysis in neuroendocrine carcinoma of the lung. Correlation with survival and histologic subtype.
Cancer, 68 (1991), pp. 374-379
[64.]
D.H. Johnson.
New drugs in the management of small cell lung cancer.
Lung Cancer, 5 (1989), pp. 221-231
[65.]
B.E. Johnson.
Management of small-cell lung cancer.
R.A.Matthay. Lung Cancer. Clin Chest Med, 14 (1993), pp. 173-187
[66.]
D.H. Johnson.
Treatment of limited-stage small cell lung cancer: Recent progress and future directions.
Lung Cancer, 9 (1993), pp. S1-S19
[67.]
D.J. Jones, P.S. Hasleton, M. Moore.
DNA ploidy in bronchopulmonaty carcinoid tumours.
Thorax, 43 (1988), pp. 195-199
[68.]
R. Karmy-Jones, E. Vallieres.
Carcinoid crisis after biopsy of a bronchial carcinoid.
Ann Thorne Surg, 56 (1993), pp. 1403-1445
[69.]
K. Karrer.
Multi-modality treatment after surgery for cure of small cell lung cancer (SCLC).
Lung Cancer, 4 (1988), pp. 153
[70.]
K. Karrer, E. Ulsperger, et al.
Surgery for cure followed by chemotherapy in small cell carcinoma of the lung.
Acta Oncologica, 34 (1995), pp. 899-906
[71.]
K. Karrer, et al.
The importance of surgical and multimodality treatment for small cell bronchial carcinoma.
J Thorac Cardiovasc Surg, 97 (1989), pp. 168-176
[72.]
R.E. Kibbelaar, et al.
Neural cell adhesion molecule expression. neuroendocrine differentiation and prognosis in lung carcinoma.
Eur J Cancer, 27 (1991), pp. 431-435
[73.]
P. Kiriakogiani-Psaropoulou, et al.
The value of neuroendocrine markers in non-small cell lung cancer: A comparative immunohistopathologic study.
Lung Cancer, 11 (1994), pp. 353-364
[74.]
J. Klatersky.
Therapy with cisplatin and etoposide for non-small-cell lung cancer.
Semm Oncol, 13 (1986), pp. 104-144
[75.]
J.A. Seculier, J.-P. Klatersky.
Intensive chemotherapy of small cell lung cancer.
Lung Cancer, 5 (1989), pp. 196-206
[76.]
H. Kreisman, N. Wolkove, E. Quoix.
Small cell lung cancer presenting as a solitary pulmonary nodule.
Chest, 101 (1992), pp. 225-231
[77.]
H. Kujari, et al.
A flow cytometric analysis of 23 carcinoid tumors.
Cancer, 61 (1988), pp. 2517-2520
[78.]
T. Lad, et al.
A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small lung cancer to combination chemotherapy.
Chest, 106 (1994), pp. 320S-323S
[79.]
J.A. Lederman.
Biological approaches to the therapy of lung cancer.
ESMO, (1994), pp. 67-71
[80.]
C. Lequaglie, I. Cataldo, F. Preda, G. Ravasi.
Clinical and prognostic assessment of resected neuroendocrine lung cancer at early stage.
pp. 235-241
[81.]
A.S. Lichter, A.T. Turrisi.
Small cell lung cancer. The influence of dose and treatment volume on outcome.
Semin Radio Oncol, 5 (1995), pp. 44-49
[82.]
R. Lima.
Bronchial adenoma. Clinicopathologic study and results of treatment.
Chest, 77 (1980), pp. 81-84
[83.]
I. Linnoila.
Pathology of non-small cell lung cancer. New diagnostic approaches.
Hemat/Oncol Clin North Am, 4 (1990), pp. 1027-1051
[84.]
R.I. Linnoila, J.L. Mulshine, S.M. Steinberg, et al.
Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Am J Chn Pathol, 90 (1988), pp. 641-652
[85.]
R.I. Linnoila, Plantadasi, J.C. Ruckdeschel.
Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience.
Chest, 106 (1994), pp. 367S-371S
[86.]
R.I. Linnoila, et al.
Neuroendocrine (NE) differentiation in non-small cell lung cancer (NSCLC) correlates with favorable response to chemotherapy (CT).
Proc Am Soc Clin Oncol, 8 (1989), pp. 248
[87.]
M.T. Magalhães Godinjjo, L.L. Leite De Noronha, E. Moreira, F. Orvalho.
Med Torac, VII (1984), pp. 117-124
[88.]
M.D. Mangum, F.A. Greco, J.D. Hainsworth, K.R. Hande, D.H. Joiinson.
Combined small-cell and non-small-cell lung cancer.
J Clin Oncol, 7 (1989), pp. 607-612
[89.]
E.J. Mark, J.F. Ramirez.
Penpheral small-cell carcinoma of the lung resembling carcinoid tumor.
Arch Pathol Lab Med, 109 (1985), pp. 263-269
[90.]
N. Martlni, M.B. Zaman, M.S. Bains, M.E. Burt, P.M. McCormack, V.W. Rusch, R.J. Ginsberg.
Treatment and prognosis m bronchial carcinoids involving regional lymph nodes.
J Thorac Cardiovasc Surg, 107 (1994), pp. 1-7
[91.]
C.-H. Marty-Ané, V. Costes, J.-L. Pujol, M. Alauzen, P. Baldet, H. Mary.
Carcinoid tumors of lung: Do a typical features require agressive management?.
Ann Thorac Surg, 59 (1995), pp. 78-83
[92.]
B.C. Mccaughan, N. Martini, M.S. Bains.
Bronchtal carcinoids. Review of 124 cases.
J Thorac Carcliovasc Surg, 89 (1985), pp. 8-17
[93.]
E.M. McDowell, T.S. Wilson, B.F. Trump.
A typical endocrine tumors of the lung.
Arch. Pathol Lab Med, 105 (1980), pp. 20-28
[94.]
C.G. Moerter, L.K. Kvols, M.J. O’Connel, J. Rubin.
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of these neoplasms.
Cancer, 68 (1991), pp. 227-232
[95.]
W.J. Mooi, K. Dingemans, N. Van Zandwijk.
Prevalence of neuroendocrine granules m small cell lung carcinoma. Usefulness of electron miroscopy in lung cancer classification.
J Pathol, 149 (1986), pp. 41-47
[96.]
W.J. Mooi, A. Dewar, D. Sprjngall, J.M. Polak, B.J. Addis.
Non small cell lung carcinomas with neuroendocrine features. A light microscopic. immunohistochemical and ultrastructural study of 11 cases.
Histopathology, 13 (1988), pp. 329-337
[97.]
W.J. Mooi, et al.
The "grey area" between small-cell and non-small cell carcinomas. Light and electron microscopy versus clinical data in 14 cases.
J Pathol, 149 (1986), pp. 49-54
[98.]
C.F. Mountain.
New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression.
Chest, 108 (1995), pp. 246-254
[99.]
L.C. Müller, R. Gasser, H. Huber, A. Klingler, G.M. Salzer.
Neuron-specific enolase (NSE) in small -cell lung cancer: Longitudinal tumor marker revaluation.
Lung Cancer, 8 (1992), pp. 29-36
[100.]
J. Mulshine, et al.
Preliminary report of a prospective trial of neuroendocrine (NE) marker analysis and in vitro drug sensisivity (IVDS) testing in patients (PTS) with non-small cell lung cancer.
Proc Am Soc Clio Oncol, (1987), pp. 713
[101.]
A.K. Naggar, et al.
Typical and atypical bronchopulmonary carcinoids. A clinicopathologic and flow cytametric study.
Am J Clin Pathol, 95 (1991), pp. 828-834
[102.]
M.H. Neal, R. Kosinski, P. Cohen, J.M. Orenstein.
Atypical endocrine tumors of the lung: A histologic, ultrastructural, and clinical study of 19 cases.
Hum Pathol, 17 (1986), pp. 1264-1277
[103.]
I. Norheim, et al.
Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization. hormone production, and survival.
Ann Surg, 206 (1987), pp. 115-125
[104.]
N. Okike, P.E. Bernatz, L.B. Woolner.
Carcinoid tumors of the lung.
Ann Thorac Surg, 22 (1976), pp. 270-275
[105.]
K. Østerlind.
Alternating or sequencial chemotherapy in small cell lung cancer?.
Lung Cancer, 5 (1989), pp. 173-177
[106.]
V. Pal, K. Frigyes, C. Attila.
Surgical treatment of bronchial carcinoid tumours.
Radical surgery-prognosis. Int Surg, 76 (1991), pp. 98-100
[107.]
R.R. Paladagu, J.R. Befield, H.V. Pak, R.K. Ross, R.L. Teplitz.
Bronchopulmonary Kulchitzky cell carcinomas. A new classification schema for typical and atypical carcinoids.
Cancer, 55 (1985), pp. 1303-1311
[108.]
D.G. Payne, et al.
The role of thoracic radiation therapy in small cell carcinoma of the lung: A consensus report.
Lung Cancer, 5 (1989), pp. 135-138
[109.]
P.A. Race, et al.
The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes.
Cancer, 50 (1982), pp. 2894-2902
[110.]
P.A. Radice, et al.
The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes.
Cancer, 50 (1982), pp. 2894-2902
[111.]
M. Ranchod.
The histogenesis and developments of pulmonary tumorlets.
Cancer, 39 (1977), pp. 1135-1145
[112.]
G.E. Richardson, B.E. Johnson.
The biology of lung cancer.
Semin Oncol, 20 (1993), pp. 105-127
[113.]
A.J.A. Robalo Cordeiro.
Marcadores bioquimicos do carcinoma brônquico.
Via Pneumológica, V (1992), pp. 17-29
[114.]
U.S. Salminen, P.E. Halttunen, S.P. Mattila, A. Sahlman, M. Miettinen.
Bronchial carcinoid: A clinical follow-up study of 33 cases.
Scand J Thorac Cardiavase Surg, 25 (1991), pp. 189-194
[115.]
V.S. Salminen, et al.
Bronchial carcinoid: A clinical follow-up study of 33 cases.
Scand J Thorne Cardiovasc Surg, 25 (1991), pp. 189-194
[116.]
A.J.M. Schreurs, et al.
A twenty-five-year follow-up of ninety-three resected typical carcinoid tumors of the lung.
J Thome Cardiovasc Surg, 104 (1992), pp. 1470-1475
[117.]
S. Sell.
Cancer markers of the 90's.
Clin Laboratory Med, 10 (1990), pp. 1-37
[118.]
M.N. Sheppard.
Neuroendocrine differentiation in lung tumours.
Thorax, 46 (1991), pp. 843-850
[119.]
M.N. Sheppard.
Immunohistochemistry and in situ hybridisation in the diagnosis and prognosis of lung cancer.
Lung Cancer, 9 (1993), pp. 119-134
[120.]
M.N. Sheppard.
Neuroendocrine differentiation in lung tumours.
pp. 30-50
[121.]
F.A. Shepherd, R.J. Ginsberg, D. Feld, W.K. Evans, E. Johansen.
Surgical treatment for limited small-cell lung cancer.
J Thorne Cardiovasc Surg, 101 (1991), pp. 385-393
[122.]
F.A. Shepherd.
A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group.
Study J Thorne Cardiovasc Surg, 97 (1989), pp. 77-186
[123.]
T.W. Shields, G.A. Higgings, M.J. Matthews, R.J. Keehn.
Surgical resection in the management of small cell carcinoma of the lung.
J Thorne Cardiovasc Surg, 84 (1982), pp. 481-488
[124.]
B.G. Skov, J.B. Sørensen, F.R. Hirsch, et al.
Prognostic impact of histologic demonstration of chromograin A and neuron specific enolase in pulmonary adenocarcinoma.
Ann Oncol, 2 (1991), pp. 355-360
[125.]
R. Sotto-Mayor.
Terapêutica ambulatória do cancro do pulmão.
pp. 81-96
[126.]
R. Sotto-Mayor.
pp. 59-80
[127.]
R. Sotto-Mayor.
Heterogeneidade tumoral.
pp. 37-44
[128.]
R. Sotto-Mayor.
Tumores neuroendócrinos do pulmão.
Rev Port Pneumol, 1 (1995), pp. 73-81
[129.]
R. Sotto-Mayor, J. Maçanita, M. Freitas E Costa.
Tumores broncopulmonares benignos. Experiência da Clínica de Doenças Pulmonares da Faculdade de Medicina de Lisboa.
Arq SPPR, IV (1987), pp. 29-35
[130.]
R. Sotto-Mayor.
A importância do antigénio carcinoembrionário (CEA) e da neuro-enolase especifica (NSE) no diagnóstico e no estadiamento do cancro do pulmão.
Via Pneumológica, III (1990), pp. 25-34
[131.]
R.L. Souhami.
Neuroendocrine phenotype, chemosensitivity and prognosis in adenocarcinoma of the lung.
Ann Oncol, 2 (1991), pp. 323-324
[132.]
T.A.W. Splinter.
Chemotherapy of small-cell lung cancer Duration of treatment.
Lung Cancer, 5 (1989), pp. 186-195
[133.]
R.A. Stahel, et al.
Staging and prognostic factors in small cell lung cancer: A consensus report.
Lung Cancer, 5 (1989), pp. 119-126
[134.]
G. Stamatis, L. Freitag, D. Greschuchna.
Limited and radical resection for tracheal and bronchopulmonary carcinoid tumour, Report on 277 cases.
Eur J Cardiothorac Surg, 4 (1990), pp. 527-532
[135.]
G.M. Strauss, A.T. Skarin.
Use of tumor markers in lung cancer.
Hemat/Oncol Clin North Am, 8 (1994), pp. 507-532
[136.]
R. Stuart-Harris, M. Boyer, M. Greenberg, S. Stevens, T. Yong.
The histopathological classification of small cell lung cancer: Application in 124 eases.
Lung Cancer, 8 (1992), pp. 63-70
[137.]
V. Sundaresan, J.G. Reeve, S. Stenning, S. Stewart, N.M. Bleehen.
Neuroendocrine differentiatian and clinical behaviour m non-small cell lung tumours.
Br J Cancer, 64 (1991), pp. 333-338
[138.]
M. Sztumowicz, et al.
Prognostic value of neuron-specific enolase in small cell lung cancer patients.
Lung Cancer, 8 (1993), pp. 259-264
[139.]
F. Thomas, R. Arriagada, T. Le Chevalier, M.F. Poupon.
Progrès récents dans la biologie du carcinome bronchique à petites cellules.
Rev Mal Reso, 5 (1988), pp. 451-461
[140.]
M.E. Teeling, D.N. Carney.
Biochemical markers of lung cancer.
pp. 43-58
[141.]
E. Teixeira.
Avanços na terapêutica do cancro do pulmão.
Curso de Pneumologia Para Pós-Graduados, (1995), pp. 199-217
[142.]
F.B.J.M. Thunnissen, J. Van EJIK, J.P.A. Baak, et al.
Bronchopulmonary carcinoids and regional lymph node metastases. A quantitative pathologic investigation.
Am J Pathol, 132 (1988), pp. 119-122
[143.]
W.D. Travis.
Classification of neuroendocrine tumors of the lung.
Lung Cancer, 11 (1994), pp. 197-198
[144.]
W.D. Travis, R.J. Linnoila, M.G. Isokos, C.L. Hitchcock, G.B. Cutler, L. Nieman, G. Chrousos, H. Pass, J. Doppman.
Neuroendocrine tumors of the lung with proposed criteria for larg-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.
Am J Surg Pathol, 15 (1991), pp. 529-553
[146.]
L. Vanmaele, et al.
Atypical ossification in bronchial carcinoid.
Eur Respir J, 3 (1990), pp. 927-929
[147.]
D.W. Visscher, R.J. Zarbo, J.Q. Trojanowski, W. Sakr, J.D. Crissman.
Neuroendocrine differentiated carcinomas: a light microscopic and immunohistologic study.
Mod Pathol, 3 (1990), pp. 508-512
[148.]
S.S. Wagenaar, H.D. Tazelaar.
Ten years after the WHO classification for lung cancer: Where ae we?.
Lung Cancer, 11 (1994), pp. S39-S43
[149.]
W.H. Warren, et al.
Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants.
J Thorac Cardiovasc Surg, 89 (1985), pp. 819-825
[150.]
W.H. Warren, L.P. Faber, V.E. Gould.
Neuroendocrine neoplasms of the Lung: a clinicopathologic update.
J Thoroc Cardiovasc Surg, 98 (1989), pp. 321-332
[151.]
W.H. Warren, V.E. Gould.
Long term follow-up of classical bronchial carcinoid tumors. Clinicopathologic observations.
Scand J Thorac Cardiovasc Surg, 24 (1990), pp. 125-130
[152.]
W.H. Warren, V.A. Memoli, V.E. Gould.
Clinical implications of histologic re-evaluation of "limited small cell lung cancer".
Lung Cancer, 4 (1988), pp. A85
[153.]
W.H. Warren, V.A. Memoli, A.G. Jordan, et al.
Reevaluation of pulmonary neoplasms resected as small cell carcinomas. Significance of distinguishing between well-differentiated and small cell neuroendocrine carcinomas.
Cancer, 65 (1990), pp. 1003-1010
[154.]
M.R. Wick, L.C. Berg, M.I. Hertz.
Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors.
Am J Clin Pathol, 97 (1992), pp. 796-805
[155.]
E.D. Williams, L.R. Celestin.
The association of bronchial carcinoid and pluriglandular adenomatosis.
Thorax, 31 (1962), pp. 212-219
[156.]
The World Health Organization Histological Typing of Lung Tumors.
2, pp. 123-136
[158.]
R. Yesner.
Pathogenesis and pathology.
R.A.Matthay. Lung Cancer. Clin Chest Med, 14 (1993), pp. 17-30
Copyright © 1995. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study
- Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options